Silmäasema Oyj Reports Un-Audited Consolidated Earnings Results for the First Quarter Ended March 31, 2018; Re-Affirm Earnings Guidance for the Year 2018
May 17, 2018
Share
Silmäasema Oyj reported un-audited consolidated earnings results for the first quarter ended March 31, 2018. For the quarter, the company reported net sales of 30.9 million compared to 29.7 million, adjusted EBITDA of 2.8 million compared to 2.8 million, operating result of 1.1 million compared to 0.8 million, adjusted operating result of 1.4 million compared to 1.6 million, profit before taxes of 0.8 million compared to 0.08 million, profit of 0.5 million or 0.04 per basic and diluted share compared to loss of 0.03 million or 0.01 per basic and diluted share, return on equity of 1.3% compared to negative of 0.4%, net cash inflow from operating activities of 4.4 million compared to 4.1 million, payments for property, plant and equipment of 2.6 million compared to 0.8 million, payments for intangible assets of 0.5 million compared to 0.3 million a year ago. Net debt as at March 31, 2018 was 32.7 million compared to 60.8 million as at March 31, 2017.
The company's net sales are estimated to grow compared to the previous year. In 2017, the company's net sales were 118.3 million. The company's adjusted EBITDA is estimated to be 9-13% of net sales.
Silmaasema Oyj is a Finland-based holding company of Silmaasema group, which offers ophthalmic goods and services. The Group is engaged in the retail of glasses, sunglasses and contact lenses, with a portfolio comprising such brands as Burberry, Dolce & Gabbana, Emporio Armani, Fendi, Furla, Gucci, Juicy Couture, Max Mara, Michael Kors, Pierre Cardin, Polaroid, Ray-Ban, Skaga, Tommy Hilfiger and Versace, among others. The Group also offers a range of healthcare services, such as eye surgery, eyelid and lens surgery, and ophthalmologist and optician services, among others. Additionally, it provides information on eye diseases and methods of treatment. The Group operates a chain of more than 120 stores and over 10 eye hospitals.
Silmäasema Oyj Reports Un-Audited Consolidated Earnings Results for the First Quarter Ended March 31, 2018; Re-Affirm Earnings Guidance for the Year 2018